Delivering Therapy Where It Matters - Webinar of 2/23/22 скачать в хорошем качестве

Delivering Therapy Where It Matters - Webinar of 2/23/22

RenovoRx (NASDAQ: RNXT) - Join CEO Shaun Bagai as he discusses RenovoRx's unique approach to fighting cancer through localized chemotherapy as well as their plans for the future. The event will include a Q&A session. Learn more about us at https://www.RenovoRx.com/ ------------------------------------------- RenovoRx is a clinical-stage biopharmaceutical company focused on fighting cancer through the localized treatment of difficult-to-treat tumors via its proprietary RenovoRx Trans-Arterial Micro-Perfusion (RenovoTAMPTM) therapy platform. RenovoTAMP utilizes approved chemotherapeutics with validated mechanisms of action and well-established safety and side effect profiles, with the goal of increasing their efficacy, improving their safety, and widening their therapeutic window. RenovoRx’s lead product candidate, RenovoGemTM, is a combination of gemcitabine and our patented delivery system, RenovoCath®, and is regulated by the FDA as a novel oncology drug product to treat unresectable locally advanced pancreatic cancer (LAPC). RenovoGem is currently being studied in the Phase 3 TIGeR-PaC trial for the treatment of LAPC. To learn visit and follow us at: Website: https://www.RenovoRx.com Facebook:   / renovorx   Twitter:   / renovorx   LinkedIn:   / renovorx